Carcelero San Martín E, Soy Muner D
Servicio de Farmacia, Hospital Clínic Barcelona, Barcelona, España.
Med Intensiva. 2013 Apr;37(3):185-200. doi: 10.1016/j.medin.2012.02.012. Epub 2012 Apr 3.
Critically ill patients are often affected by infections produced by Pseudomonas, which can be a cause of sepsis and renal failure. Early and adequate antibiotic treatment at correct dosage levels is crucial. Acute kidney injury is also frequent in critically ill patients. In those patients who require renal replacement therapy, continuous techniques are gaining relevance as filtering alternatives to intermittent hemodialysis. It must be taken into account that many antibiotics are largely cleared by continuous renal replacement therapies (CRRT). The aim of this review is to assess the clinical evidence on the pharmacokinetics and dosage recommendations of the main antibiotic groups used to treat Pseudomonas spp. infections in critically ill patients subjected to CRRT.
重症患者常受铜绿假单胞菌感染影响,这可能是败血症和肾衰竭的一个病因。以正确剂量水平进行早期且充分的抗生素治疗至关重要。急性肾损伤在重症患者中也很常见。在那些需要肾脏替代治疗的患者中,连续性技术作为间歇性血液透析的过滤替代方法正变得越来越重要。必须考虑到许多抗生素在很大程度上会被连续性肾脏替代治疗(CRRT)清除。本综述的目的是评估关于用于治疗接受CRRT的重症患者铜绿假单胞菌属感染的主要抗生素组的药代动力学和剂量推荐的临床证据。